TMS Co Ltd

NEW
TSE:4891 (Japan)  
円 103 -1 (-0.96%) Jul 8
At Loss
P/B:
1.69
Market Cap:
円 4.69B ($ 28.90M)
Enterprise V:
円 1.91B ($ 11.77M)
Volume:
174.40K
Avg Vol (2M):
332.18K
Trade In:
Volume:
174.40K
At Loss

Business Description

Description
TMS Co Ltd is focused on researching, developing, manufacturing, and selling pharmaceuticals. The company is involved in conducting research and development of SMTP compounds, which are drug candidate substances targeting soluble epoxide hydrolase (sEH), an enzyme found in the human body. It is developing sEH inhibitors for various inflammatory diseases. The company's clinical pipeline comprises three compounds: TMS-007 (being developed as a potential treatment for acute cerebral infarction), which is in the late clinical stage, TMS-010, and JX09 (for resistant and poorly controlled hypertension) and TMS-008 (to target acute inflammatory diseases such as kidney injury and cancer cachexia), which are in the early clinical stage. In addition, it has TMS-009 as a backup compound for TMS-008.
Name Current Vs Industry Vs History
Cash-To-Debt
No Debt
Equity-to-Asset
0.97
Piotroski F-Score
3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Book Growth Rate
1.3
Name Current Vs Industry Vs History
5-Day RSI
28.2
9-Day RSI
31.75
14-Day RSI
31.51
3-1 Month Momentum %
-15.49
6-1 Month Momentum %
-14.89
12-1 Month Momentum %
-27.71

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
30.42
Quick Ratio
30.41
Cash Ratio
29.54

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
-3.3
Name Current Vs Industry Vs History
ROE %
-16.71
ROA %
-15.94
ROIC %
-491.12
3-Year ROIIC %
13208.3
ROCE %
-16.18
Years of Profitability over Past 10-Year
1

Financials

TSE:4891's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

TMS Co Ltd Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil 円)
EPS (TTM) (円) -11.11
Beta 0.7277
3-Year Sharpe Ratio -0.46
3-Year Sortino Ratio -0.71
Volatility % 35.4
14-Day RSI 31.51
14-Day ATR (円) 4.72978
20-Day SMA (円) 108.55
12-1 Month Momentum % -27.71
52-Week Range (円) 99 - 185
Shares Outstanding (Mil) 45.57

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

TMS Co Ltd Filings

Filing Date Document Date Form
No Filing Data

TMS Co Ltd Stock Events

Financials Calendars
Event Date Price (円)
No Event Data

TMS Co Ltd Frequently Asked Questions

What is TMS Co Ltd(TSE:4891)'s stock price today?
The current price of TSE:4891 is 円103.00. The 52 week high of TSE:4891 is 円185.00 and 52 week low is 円99.00.
When is next earnings date of TMS Co Ltd(TSE:4891)?
The next earnings date of TMS Co Ltd(TSE:4891) is .
Does TMS Co Ltd(TSE:4891) pay dividends? If so, how much?
TMS Co Ltd(TSE:4891) does not pay dividend.

Press Release

Subject Date
No Press Release

Articles on TMS Co Ltd

No articles.